Compare IKT & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IKT | FCCO |
|---|---|---|
| Founded | 2008 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.3M | 228.0M |
| IPO Year | 2020 | 1998 |
| Metric | IKT | FCCO |
|---|---|---|
| Price | $1.59 | $30.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 519.5K | 78.6K |
| Earning Date | 11-14-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 2.09% |
| EPS Growth | N/A | ★ 36.46 |
| EPS | N/A | ★ 2.47 |
| Revenue | N/A | ★ $78,007,000.00 |
| Revenue This Year | N/A | $30.67 |
| Revenue Next Year | N/A | $5.87 |
| P/E Ratio | ★ N/A | $12.39 |
| Revenue Growth | N/A | ★ 19.77 |
| 52 Week Low | $1.33 | $19.46 |
| 52 Week High | $3.32 | $31.50 |
| Indicator | IKT | FCCO |
|---|---|---|
| Relative Strength Index (RSI) | 43.36 | 64.44 |
| Support Level | $1.49 | $28.76 |
| Resistance Level | $1.61 | $29.85 |
| Average True Range (ATR) | 0.10 | 0.85 |
| MACD | -0.02 | 0.17 |
| Stochastic Oscillator | 22.08 | 81.66 |
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.